CAN B CORP

NASDAQ: CANB (CAN B CORP.)

Kemas kini terakhir: 28 Nov, 7:48PM

0.021

0.00 (10.53%)

Penutupan Terdahulu 0.019
Buka 0.020
Jumlah Dagangan 20,590
Purata Dagangan (3B) 343,548
Modal Pasaran 1,592,682
Harga / Pendapatan (P/E TTM) 0.233
Harga / Jualan (P/S) 0.930
Harga / Buku (P/B) 33.49
Julat 52 Minggu
0.003 (-85%) — 0.184 (776%)
Tarikh Pendapatan 18 Aug 2025 - 22 Aug 2025
Margin Operasi (TTM) -18,553.67%
EPS Cair (TTM) 0.090
Pertumbuhan Hasil Suku Tahunan (YOY) -96.40%
Nisbah Semasa (MRQ) 0.140
Aliran Tunai Bebas Leveraj (LFCF TTM) 1.67 M
Pulangan Atas Aset (ROA TTM) -62.52%

Arah Aliran Pasaran

Jangka Pendek Jangka Sederhana
Industri Drug Manufacturers - Specialty & Generic (US) Menaik Bercampur
Drug Manufacturers - Specialty & Generic (Global) Menaik Bercampur
Stok CAN B CORP. - -

AISkor Stockmoo

0.9
Konsensus Penganalisis 2.0
Aktiviti Orang Dalam NA
Volatiliti Harga -2.0
Purata Bergerak Teknikal 2.5
Osilator Teknikal 1.0
Purata 0.88

Saham Serupa

Stok Modal Pasaran DY P/E (TTM) P/B
CANB 2 M - 0.233 33.49
BIOA 335 M - 0.687 1.10
CTOR 114 M - - 2.89
ZYBT 104 M - 73.33 2.47
GELS 12 M - - 1.11
SHPH 2 M - - 1.84

Can B Corp., a health and wellness company, develops, manufactures, and sells hemp derived products in the United States. The company provides CBD products derived from hemp, including oils, creams, moisturizers, isolate, gel caps, spa products, concentrates, and lifestyle products. It sells its products under the Canbiola, Nu Wellness, Seven Chakras, and Pure Leaf Oil brands through medical professionals, website, and vending machines. The company also produces industrial hemp, and processes hemp biomass, isolate, and isomers, such as CBN, CBG, delta-8, and delta-10; and manufactures and sells durable medical equipment. The company was formerly known as Canbiola Inc. and changed its name to Can B Corp. in February 2020. Can B Corp. was incorporated in 2005 and is based in Hicksville, New York.

Sektor Healthcare
Industri Drug Manufacturers - Specialty & Generic
% Dimiliki oleh Orang Dalam 3.38%
% Dimiliki oleh Institusi 0.95%

Tiada data dalam julat masa ini.

Tiada data dalam julat masa ini.

Tarikh Jenis Butiran
16 Sep 2025 Pengumuman Nascent Pharma Holdings, Inc. Announces Name and Symbol Change

Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.

Portfolio

AI Templat

Peringatan harga anda

Profil Risiko

| | | | |
Konservatif
Sederhana Konservatif
Sederhana
Sederhana Agresif
Agresif
Margin Keselamatan (EP)
Keuntungan Separa (TP1)
Keuntungan Sasaran (TP2)
Kerugian Maksimum (SL)

Penafian: Perkara di atas adalah untuk tujuan ilustrasi sahaja dan BUKAN nasihat pelaburan. Dapatkan nasihat daripada penasihat kewangan yang berkelayakan.

Harga Masuk (EP)

Ambil Untung 1 (TP1)

Ambil Untung 2 (TP2)

Henti Rugi (SL)

Julat 52 Minggu
 
52WL
 
52WH
SL
EP
TP1
TP2

Semua harga peringatan berada dalam julat harga 52 minggu

Keuntungan Nyata -
Keuntungan Tidak Nyata -
Dividen Diterima 2025 -
Jumlah Untung -
Pulangan Purata -
Kuantiti (Beli) -
Purata Harga (Beli) -
Kuantiti (Jual) -
Purata Harga (Jual) -
Tiada saham yang memenuhi kriteria anda